New dengue vaccine shows promise in early trial
NCT ID NCT03746015
First seen Oct 31, 2025 · Last updated May 02, 2026 · Updated 20 times
Summary
This study tested a new dengue vaccine in 30 healthy adults, some with prior dengue exposure and some without. The goal was to see how well the vaccine triggers the immune system to fight all four types of dengue virus. Researchers measured antibody levels over 12 months to check the vaccine's effectiveness and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Optimal Research
Peoria, Illinois, 61614, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.